The facts: World population is expected to reach 9.7 billion people by 2050. Today, one quarter of the population suffers from malnutrition. Available land and water are diminishing, and cultural and economic changes are creating greater demand for meat – leading to need for more crops, feed and water, animal care.
Solutions will not come from traditional methods, plowing more land or raising more animals. Solutions will come from innovation.
In 2014, TechAccel’s founders imagined a new way to invest in solutions while also supporting the advancement of agriculture and animal health industries. We call this approach “Equity+.” We believe collaboration is the engine of success.
TechAccel’s founders knew from firsthand experience that good ideas don’t always make it across the finish line.
Often ideas are stranded – either in research labs when federal funding falters, in emerging companies when equity isn’t available, even at global industrial firms when priorities shift and promising innovations are left on the shelf. Think of No. 11 on the list when the R&D funding extends only to No. 10.
The TechAccel model was formed to bridge the gap. TechAccel makes equity investments or licenses the technology, and then launches science advancement initiatives to push the technology forward. That’s the “Equity+.” Often, the science advancement led to “extra shots on goal” by adapting technology for an adjacent market.
Leading agriculture and animal health research universities and institutions signed on as partners. They bring innovations and research experts who perform science advancement work under TechAccel direction.
Global leaders like having products “de-risked” outside their walls, speeding up the process.
Emerging companies get help with equity and science advancement, in related areas, without having to take their eyes off their core targets.
And equity investors appreciate the improved odds. It wasn’t long before VCs started pulling TechAccel into strategic investments.